Announcements Trials
Browse Landscape

Phase

Phase 2/3 1Phase 2 1Phase 1/2 1

Status

Completed 2Terminated 1

Sponsor Class

NIH 12OTHER 3INDUSTRY 2

Study Type

Interventional 3

Sponsor

Cancer Type

Sarcoma 1Gynecologic 1Breast 1

Conditions

Recurrence 1Ovarian Neoplasms 1Osteosarcoma 1Fallopian Tube Neoplasms 1Breast Neoplasms 1

Interventions

Cyclophosphamide 548pembrolizumab 385Radiotherapy 363Bevacizumab 360Carboplatin 351Rituximab 315Cisplatin 300Gemcitabine 297Paclitaxel 288Dexamethasone 272Docetaxel 271fludarabine phosphate 241Doxorubicin 231Nivolumab 220Etoposide 209Cytarabine 203Lenalidomide 201fludarabine 191Oxaliplatin 191Fluorouracil 190Melphalan 189Filgrastim 188Capecitabine 175Calcium Dobesilate 172Radiosurgery 167Erlotinib Hydrochloride 167Methotrexate 163Bortezomib 162Granulocyte Colony-Stimulating Factor 154Whole-Body Irradiation 144

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Has results × saracatinib × Clear all
NCT01216176 2025-01-08

A Pharmacokinetic and Randomized Trial of Neoadjuvant Treatment With Anastrozole Plus AZD0530 in Postmenopausal Patients With Hormone Receptor Positive Breast Cancer

University of Miami

Phase 1/2 Completed
71 enrolled 15 charts
Breast

Breast Neoplasms

NCT00752206 2020-01-18

A Placebo-Controlled Study of Saracatinib (AZD0530) in Patients With Recurrent Osteosarcoma Localized to the Lung

Sarcoma Alliance for Research through Collaboration

Phase 2 Terminated
38 enrolled 10 charts
Sarcoma

Recurrence, Osteosarcoma

NCT01196741 2015-05-05

SaPPrOC

University College, London

Phase 2/3 Completed
107 enrolled 17 charts
Gynecologic

Fallopian Tube Neoplasms, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡